PASG
Price
$10.57
Change
-$0.42 (-3.82%)
Updated
Feb 4 closing price
Capitalization
34.52M
Intraday BUY SELL Signals
PTHS
Price
$23.31
Change
-$0.05 (-0.21%)
Updated
Feb 4 closing price
Capitalization
75.42M
20 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

PASG vs PTHS

Header iconPASG vs PTHS Comparison
Open Charts PASG vs PTHSBanner chart's image
Passage Bio
Price$10.57
Change-$0.42 (-3.82%)
Volume$32.43K
Capitalization34.52M
Pelthos Therapeutics
Price$23.31
Change-$0.05 (-0.21%)
Volume$6.96K
Capitalization75.42M
PASG vs PTHS Comparison Chart in %
PASG
Daily Signal:
Gain/Loss:
PTHS
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
PASG vs. PTHS commentary
Feb 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PASG is a Hold and PTHS is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 05, 2026
Stock price -- (PASG: $10.99 vs. PTHS: $23.36)
Brand notoriety: PASG and PTHS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PASG: 54% vs. PTHS: 53%
Market capitalization -- PASG: $34.52M vs. PTHS: $75.42M
PASG [@Biotechnology] is valued at $34.52M. PTHS’s [@Biotechnology] market capitalization is $75.42M. The market cap for tickers in the [@Biotechnology] industry ranges from $119.38B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PASG’s FA Score shows that 1 FA rating(s) are green whilePTHS’s FA Score has 0 green FA rating(s).

  • PASG’s FA Score: 1 green, 4 red.
  • PTHS’s FA Score: 0 green, 5 red.
According to our system of comparison, PASG is a better buy in the long-term than PTHS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PASG’s TA Score shows that 3 TA indicator(s) are bullish while PTHS’s TA Score has 3 bullish TA indicator(s).

  • PASG’s TA Score: 3 bullish, 6 bearish.
  • PTHS’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, both PASG and PTHS are a bad buy in the short-term.

Price Growth

PASG (@Biotechnology) experienced а -12.78% price change this week, while PTHS (@Biotechnology) price change was -9.75% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.56%. For the same industry, the average monthly price growth was +1.40%, and the average quarterly price growth was +33.10%.

Reported Earning Dates

PTHS is expected to report earnings on Feb 25, 2026.

Industries' Descriptions

@Biotechnology (-2.56% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PTHS($75.4M) has a higher market cap than PASG($34.5M). PASG YTD gains are higher at: -6.864 vs. PTHS (-24.645). PTHS has higher annual earnings (EBITDA): -22.24M vs. PASG (-45.81M). PASG has more cash in the bank: 52.8M vs. PTHS (14.2M). PTHS has less debt than PASG: PTHS (3.48M) vs PASG (24.3M). PTHS has higher revenues than PASG: PTHS (7.41M) vs PASG (0).
PASGPTHSPASG / PTHS
Capitalization34.5M75.4M46%
EBITDA-45.81M-22.24M206%
Gain YTD-6.864-24.64528%
P/E Ratio0.03N/A-
Revenue07.41M-
Total Cash52.8M14.2M372%
Total Debt24.3M3.48M698%
FUNDAMENTALS RATINGS
PASG: Fundamental Ratings
PASG
OUTLOOK RATING
1..100
78
VALUATION
overvalued / fair valued / undervalued
1..100
14
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
37
P/E GROWTH RATING
1..100
99
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
PASGPTHS
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
85%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 13 days ago
84%
Declines
ODDS (%)
Bearish Trend 7 days ago
90%
Bearish Trend 16 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 6 days ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
PASG
Daily Signal:
Gain/Loss:
PTHS
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PXS3.300.02
+0.61%
Pyxis Tankers
DIS104.22-0.23
-0.22%
Walt Disney Company (The)
CBIO9.54-0.28
-2.85%
Crescent Biopharma Inc
PATH12.15-0.39
-3.11%
UiPath
STGW5.43-0.64
-10.54%
Stagwell

PASG and

Correlation & Price change

A.I.dvisor indicates that over the last year, PASG has been loosely correlated with AXON. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if PASG jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PASG
1D Price
Change %
PASG100%
-8.95%
AXON - PASG
43%
Loosely correlated
-1.89%
CYTK - PASG
38%
Loosely correlated
-0.66%
QTTB - PASG
38%
Loosely correlated
+6.28%
ARRY - PASG
35%
Loosely correlated
+1.71%
DRUG - PASG
33%
Loosely correlated
-3.12%
More

PTHS and

Correlation & Price change

A.I.dvisor indicates that over the last year, PTHS has been loosely correlated with KLRS. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if PTHS jumps, then KLRS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PTHS
1D Price
Change %
PTHS100%
-7.67%
KLRS - PTHS
43%
Loosely correlated
+0.33%
LIXT - PTHS
34%
Loosely correlated
-5.06%
PASG - PTHS
33%
Poorly correlated
-8.95%
CRIS - PTHS
25%
Poorly correlated
-0.11%
CGTX - PTHS
24%
Poorly correlated
-1.75%
More